<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2024</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>32</volume>
<number>155</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluating the Effects of Environmental and Culture Conditions on Anti-HER2 scFv Expression and Solubility in E. coli</title>
	<subject_fa>Bionanotechnology</subject_fa>
	<subject>Bionanotechnology</subject>
	<content_type_fa>مقاله پژوهشی</content_type_fa>
	<content_type>Original Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Background &amp; Objective&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &amp;nbsp;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Breast cancer is an international concern due to its high prevalence worldwide. Human epidermal growth&lt;b&gt; &lt;/b&gt;factor receptor 2 (HER2)-positive breast cancers were observed in 15-20% of breast cancers, with higher aggressiveness and poor prognosis. The single-chain fragment variable (scFv) structure includes variable regions of antibody light and heavy chains. Despite the promising potential of anti-HER2 scFv for non-invasive detection of HER2 status, its low expression and solubility remain significant challenges. Here, we intended to optimize the&lt;b&gt; &lt;/b&gt;anti-HER2 scFv expression and solubility in BL21-pET-22 (anti-HER2 scFv).&lt;b&gt; &lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;&amp;nbsp;Materials &amp; Methods:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt; &amp;nbsp;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;The effects of ethanol stress, aeration, post-induction temperatures, induction-starting times, culture mediums, and MgCl&lt;sub&gt;2&lt;/sub&gt; addition were examined.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span lang=&quot;EN-IN&quot; style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;letter-spacing:-.1pt&quot;&gt;We observed that ethanol stress (1% v/v) increased protein expression and decreased protein solubility at 37 &amp;deg;C. However, it enhanced anti-HER2 scFv solubility at lower post-induction temperature (22 &amp;deg;C). Induction at OD&lt;sub&gt;600&lt;/sub&gt;=1 elevated anti-HER2 scFv expression, along with a substantial protein solubility enhancement at OD&lt;sub&gt;600&lt;/sub&gt;=0.6-0.8. In the LB medium, speeding up the shakers to 250 RPM led to a non-significant enhancement of anti-HER2 expression and a significant solubility improvement. The best medium for the optimum anti-HER2 scFv expression and solubility was the TB medium. MgCl&lt;sub&gt;2&lt;/sub&gt; could not increase anti-HER2 expression or solubility. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;background:#2d7f8f&quot;&gt;&lt;span style=&quot;color:white&quot;&gt;Conclusion: &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&amp;nbsp;&lt;/b&gt;&lt;span style=&quot;font-size:9.0pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;The highest anti-HER2 scFv expression level was obtained when BL21-pET-22 (anti-HER2 scFv) was cultured in TB medium, induced at OD&lt;sub&gt;600&lt;/sub&gt;=2 and 37 &amp;deg;C, and incubated at 250 RPM. The highest solubility was also observed in the TB medium, induced at OD&lt;sub&gt;600&lt;/sub&gt;=0.6-0.8 and 37 &amp;deg;C, and incubated at 250 RPM.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Breast Neoplasms, Antibody Fragments, HER2 (Receptor, ErbB-2), Protein expression, Solubility</keyword>
	<start_page>438</start_page>
	<end_page>448</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-5199-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Taranom</first_name>
	<middle_name></middle_name>
	<last_name>Mobasheri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>taranom_1997@yahoo.com</email>
	<code>5200319475328460089672</code>
	<orcid>5200319475328460089672</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali</first_name>
	<middle_name></middle_name>
	<last_name>Sharafi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sharafi.a@gmail.com</email>
	<code>5200319475328460089673</code>
	<orcid>5200319475328460089673</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Elham</first_name>
	<middle_name></middle_name>
	<last_name>Mohit</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>el_mohit@yahoo.com</email>
	<code>5200319475328460089674</code>
	<orcid>5200319475328460089674</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
